HOME › DRUGS › LUSUTROMBOPAG
ACTIVE SUBSTANCE / INN

LUSUTROMBOPAG

Brand name(s): MULPLETA, Mulpleo (previously Lusutrombopag Shionogi)
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
Thrombocytopenia
NDA210923
ACTIVE SUBSTANCE
Lusutrombopag
REGULATORS
FDA · EMA
SPONSORS / MAH
VANCOCIN ITALIA, Shionogi B.V.
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
MULPLETANDA210923VANCOCIN ITALIAPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
Mulpleo (previously Lusutrombopag Shionogi)Shionogi B.V.Authorised18/02/2019Thrombocytopenia

FULL INTELLIGENCE ON LUSUTROMBOPAG

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →